MoonLake Immunotherapeutics MLTX Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$69.71M-10.6% | -$63.02M+10.9% | -$70.69M-26.1% | -$56.05M-38.2% | -$40.56M+12.6% | ||
| $845K+12.5% | $751K+0.8% | $745K+0.4% | $742K+96.3% | $378K+3.8% | ||
| $13.36M+272% | $3.59M-3.2% | $3.71M+12.1% | $3.31M+44.5% | $2.29M+18.4% | ||
| -$66.29M-12.7% | -$58.79M-32.0% | -$44.54M+18.3% | -$54.53M-43.0% | -$38.14M+21.3% | ||
| $0— | —— | —— | —— | $35K-80.1% | ||
| $98K— | —— | $88.4M+0.2% | $88.25M+56.9% | $56.25M+138% | ||
| $24.47M— | —— | —— | —— | $73.02M— | ||
| $30.64M-57.7% | $72.4M+14,982% | $480K— | $0-100% | $73.12M+48,325% | ||
| -$36.03M— | —— | $44.06M+25.5% | $35.12M-61.5% | $91.14M+147% | ||
| -$66.29M-12.7% | -$58.79M-32.0% | -$44.54M+18.3% | -$54.53M-42.8% | -$38.18M+21.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does MoonLake Immunotherapeutics generate?
- MoonLake Immunotherapeutics (MLTX) generated -$224.2M in operating cash flow over the trailing twelve months.
- What is MoonLake Immunotherapeutics's free cash flow?
- After $343.0K of capital expenditures, MoonLake Immunotherapeutics's free cash flow was -$224.2M over the trailing twelve months, down 60.0% year over year.
- Where does MoonLake Immunotherapeutics's cash flow data come from?
- Every line is extracted from MoonLake Immunotherapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.